Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Pharmacovigilance-Patients'

Pharmacovigilance-Patients published presentations and documents on DocSlides.

Pharmacovigilance: challenges facing WHO
Pharmacovigilance: challenges facing WHO
by debby-jeon
Shanthi Pal. Leader, Medicines Safety. Safety . a...
Introduction to pharmacovigilance
Introduction to pharmacovigilance
by ellena-manuel
Monitoring the safety of medicines. Pharmacovigil...
Pharmacovigilance: challenges facing WHO
Pharmacovigilance: challenges facing WHO
by celsa-spraggs
Shanthi Pal. Leader, Medicines Safety. Safety . a...
Pharmacovigilance 1 Dr. Ganesh Uchit
Pharmacovigilance 1 Dr. Ganesh Uchit
by liane-varnes
, MD. Pfizer, India. DISCLAIMER. Overview. Intr...
Social Pharmacy and Pharmacovigilance
Social Pharmacy and Pharmacovigilance
by debby-jeon
JAMASOFT2017. 1. Social. Pharmacy. Pharmacoepide...
Introduction to Pharmacovigilance
Introduction to Pharmacovigilance
by lindy-dunigan
& . Adverse Drug Reactions . Reporting system...
Aspects of pharmacovigilance: Public hearings
Aspects of pharmacovigilance: Public hearings
by sean858
A public hearing is a forum to which the public is...
Pharmacovigilance and drug safety trainings to increase Tuberculosis (TB) preventive treatment (TPT
Pharmacovigilance and drug safety trainings to increase Tuberculosis (TB) preventive treatment (TPT
by karsyn769
Authors: . 1. Juliet Jokwiro, . 1. Nicole Chekuda...
Vaccine Pharmacovigilance
Vaccine Pharmacovigilance
by mia
Definition- . According to the CIOMS/WHO working g...
Principles of Risk Management
Principles of Risk Management
by desha
No medicine is without . risk and the.  . benefi...
Clin Pract
Clin Pract
by blanko
1466 Nikhil GuptaKavita BahmaniAjit Jangra Introdu...
Country Experience in Monitoring New
Country Experience in Monitoring New
by fauna
ARVs: Focus on Toxicity Monitoring . and Surveill...
Prospects and Challenges of Providing
Prospects and Challenges of Providing
by mitsue-stanley
Prospects and Challenges of Providing Pharmacovi...
Prospects and Challenges of Providing
Prospects and Challenges of Providing
by mitsue-stanley
Prospects and Challenges of Providing Pharmacovi...
Pharmacovigilance: New challenges for WHO
Pharmacovigilance: New challenges for WHO
by pamella-moone
Dr Shanthi Pal. . Group Lead, Medicines Safety ....
Toolkit for research and development of paediatric antiretroviral drugs and formulations
Toolkit for research and development of paediatric antiretroviral drugs and formulations
by luanne-stotts
Module 10:. Pharmacovigilance. Background – def...
Pharmacovigilance:
Pharmacovigilance:
by kittie-lecroy
New challenges for WHO. Dr Shanthi Pal. . Group ...
Post Market Surveillance
Post Market Surveillance
by alida-meadow
KNH/UON . Pharmacy Symposium. Optimizing Medicine...
Pharmacovigilance:
Pharmacovigilance:
by lois-ondreau
New challenges for WHO. Dr Shanthi Pal. . Group ...
Benefits of a strong collaboration with patient groups
Benefits of a strong collaboration with patient groups
by min-jolicoeur
at national . and EU level. Susanna Palkonen, Dir...
Off-label Use Off-label use of medicines is
Off-label Use Off-label use of medicines is
by karlyn-bohler
NOT. regulated by EU legislation and no uniform ...
 International Nonproprietary
 International Nonproprietary
by amber
N. ames. Contents . General Introduction . Element...
Medication errors within PV Centers
Medication errors within PV Centers
by SexyBeast
Pr. . Rachida. . Soulaymani. . Bencheikh. Centre...
Pharmacovigilance in Clinical Trials
Pharmacovigilance in Clinical Trials
by lucinda
Version 04 . Feb. 2021. In . this. . training co...
About OMICS Group OMICS Group is an amalgamation of
About OMICS Group OMICS Group is an amalgamation of
by phoebe-click
Open Access Publications. and worldwide internat...
The GVS blueprint and its implementation
The GVS blueprint and its implementation
by alexa-scheidler
. Dr Madhava Ram. Medical Officer. EMP/ SAV. Uns...
8 September 2014EMA//2011Rev 1*Guideline on good pharmacovigilance pra
8 September 2014EMA//2011Rev 1*Guideline on good pharmacovigilance pra
by giovanna-bartolotta
Draft Revision 1 agreed by ERMS FG29 May 2013 Draf...
September EMA Inspections and Human Medicines Pharmacovigilance D ivision Questions answers on signal management This document addresses a number of questions which stakeholders in particular marke
September EMA Inspections and Human Medicines Pharmacovigilance D ivision Questions answers on signal management This document addresses a number of questions which stakeholders in particular marke
by alida-meadow
If you have a question on signal managem ent that...
JanuaryEMA/118465/2012Guideline on good pharmacovigilance practice(GVP
JanuaryEMA/118465/2012Guideline on good pharmacovigilance practice(GVP
by faustina-dinatale
Draft agreed by ERMS FG20 July 2012 Draft adopted ...
Guideline on good pharmacovigilance practices (GVP)Module II Pharmacov
Guideline on good pharmacovigilance practices (GVP)Module II Pharmacov
by pasty-toler
9 April EMA/816573/2011Rev 1* Draft agreed by ERM...
Table Stock Incidence Malaysia Dialysis Patients Patients
Table Stock Incidence Malaysia Dialysis Patients Patients
by reece880
Sunita Bavanandan. Hooi Lai Seong. Ong Loke Meng. ...
Prevention of venous thromboembolism in surgical patients, medical patients and long-distance trave
Prevention of venous thromboembolism in surgical patients, medical patients and long-distance trave
by joy
Educational Slide Kit . American Society of Hemato...
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
by GratefulHeart
Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...
Immunizing Adult Patients Standards for PracticeYour patients trust y
Immunizing Adult Patients Standards for PracticeYour patients trust y
by payton
received all the vaccines they needEven though mos...
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Y
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Y
by debby-jeon
of . Age. . Hiromichi. Suzuki, Tsutomu . Inoue,...
Integrated care model For Vulnerable Patients in primary care
Integrated care model For Vulnerable Patients in primary care
by alessandro240
Gina Rowlands. Managing Director. Bevan Healthcare...
RAMP-UP: Pharmacist-led Rapid Access to Methadone Maintenance for Patients with OUD at Penn
RAMP-UP: Pharmacist-led Rapid Access to Methadone Maintenance for Patients with OUD at Penn
by zahir465
AMERSA 2023. November 1, 2023. Emily Casey, PharmD...
Self-sampling tools for cancer screening in primary care: Evidence from a randomized trial with underserved patients
Self-sampling tools for cancer screening in primary care: Evidence from a randomized trial with underserved patients
by paxton651
in primary care: . Evidence from a randomized tria...
2015 American Thyroid Association Management Guidelines for adult patients Differentiated Thyroid Cancer Dr.Lilianne Haj Hassan 29/3/2016
2015 American Thyroid Association Management Guidelines for adult patients Differentiated Thyroid Cancer Dr.Lilianne Haj Hassan 29/3/2016
by eliseo
Dr.Lilianne. Haj Hassan. 29/3/2016. Thyroid carci...
Poorer Health-Related Quality of Life Among Patients Who Report Adverse Events while on Treatment for Drug-Resistant TB in Johannesburg, South Africa
Poorer Health-Related Quality of Life Among Patients Who Report Adverse Events while on Treatment for Drug-Resistant TB in Johannesburg, South Africa
by edward
of . Life Among Patients Who Report Adverse Events...